(Q35857178)

10 August 2017

1 reference

title

Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. (English)

1 reference

10 August 2017

1 reference

Peter Van Buren

1

1 reference

10 August 2017

Ruben L Velez

series ordinal

2

1 reference

10 August 2017

Nosratola D Vaziri

series ordinal

3

1 reference

10 August 2017

Xin J Zhou

series ordinal

4

1 reference

10 August 2017

10 July 2011

1 reference

International Urology and Nephrology

10 August 2017

1 reference

10 August 2017

44

1 reference

10 August 2017

2

1 reference

10 August 2017

499-507

1 reference

Oxidative stress and endothelial dysfunction in hypertension

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Aspects of immune dysfunction in end-stage renal disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Ferumoxytol for treating iron deficiency anemia in CKD

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Parenteral iron nephrotoxicity: potential mechanisms and consequences

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Labile iron in parenteral iron formulations: a quantitative and comparative study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Influence of parenteral iron preparations on non-transferrin bound iron uptake, the iron regulatory protein and the expression of ferritin and the divalent metal transporter DMT-1 in HepG2 human hepatoma cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Biochemistry and molecular cell biology of diabetic complications

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Hematocrit levels and hospitalization risks in hemodialysis patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: an ESR spin-trapping investigation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Low molecular weight intracellular iron transport compounds

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

The normal hematocrit cardiac trial revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Iron chelation improves endothelial function in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

On the nature of proteinuria with acute renal injury in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-0028-5

FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Impact of iron dextran on polymorphonuclear cell function among hemodialysis patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3314165

Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time

24 September 2018

1 reference

12 December 2020

Proinflammatory effects of iron sucrose in chronic kidney disease

1 reference

12 December 2020

Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis

1 reference

12 December 2020

Oxidative stress and inflammation in hemodialysis patients

1 reference

12 December 2020

'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%

1 reference

12 December 2020

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target

1 reference

12 December 2020

Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease

1 reference

12 December 2020

Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography

1 reference

12 December 2020

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

12 December 2020

Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease

1 reference

12 December 2020

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease

1 reference

12 December 2020

Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes

1 reference

12 December 2020

Hematocrit level and associated mortality in hemodialysis patients

1 reference

12 December 2020

Characteristics of iron dextran utilization in man

1 reference

12 December 2020

Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease

1 reference

12 December 2020

Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease

1 reference

12 December 2020

Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis

1 reference

12 December 2020

10.1007/S11255-011-0028-5

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

21744260

1 reference